Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 52 (RPL23AP52)

Target
RPL23AP52
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RPL23AP52 is a processed pseudogene of the ribosomal protein L23a gene. It does not produce a functional protein and is not known to have an independent biological role in humans. Pseudogenes like RPL23AP52 arise by duplication or retrotransposition events and typically retain sequence similarity to their parent gene but accumulate mutations that disrupt their coding potential. Unlike RPL23A, a functional ribosomal protein involved in protein synthesis and potentially linked to cancer, pseudogene 52 is catalogued in the human genome as a non-coding sequence without demonstrated expression or regulatory activity. Its nomenclature and classification are standardized by the HUGO Gene Nomenclature Committee (HGNC).

Other names
RPL23A_19_784RPL23AP52
02

Biological functions

No confirmed function (Pseudogenes do not typically encode functional proteins; some studies suggest possible roles in gene regulation, but no data specific to RPL23AP52)
03

Disease associations

None identified (No literature links RPL23AP52 to a disease role, unlike its parent gene RPL23A, which has cancer associations)

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 52 (RPL23AP52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 52 (RPL23AP52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call